OIG Semiannual Report to Congress Shows 11:1 Return On Investment
The Department of Health and Human Services (HHS) Office of Inspector General (OIG) recently released its Semiannual Report to Congress summarizing program integrity efforts from October 2024 through March 2025 which showed a return of $11 for every $1 spent. The OIG is the lead federal agency combating healthcare fraud, waste, and abuse in federal programs such as Medicare, Medicaid and providers will likely see increased activity based on President Donald Trump’s goals to pay for the One Big Beautiful Bill Act.
OIG Highlights from October 1, 2024 – March 31, 2025:
- 78 reports issued
- 946 investigations closed
- 1,503 excluded individuals and entities
- 298 criminal informations and indictments (formal accusations)
- 1,209 referrals (to prosecutors)
- 349 criminal actions (convictions)
- 395 civil actions
OIG oversight impacting pharmacies includes:
- Medicare Part D improperly paid up to $465 million for drugs when payment was available under Medicare Part A over a 3-year period
- Medicare may have improperly paid up to $454 million for 39 million OTC COVID-19 tests in excess of the monthly limit of eight tests per enrollee
- Compounded prescriptions and HIV medications continue to be targets of FWA
Analyst at PAAS National®
As an Analyst, I focus on providing pre- and post-audit assistance, answering various member service questions, and researching & drafting articles for the Third-Party Newsline. I work with many of our members involved with invoice audits.
I obtained my PharmD from the University of Wisconsin-Madison School of Pharmacy and worked for a major chain as well as various LTC and independent pharmacies, before coming to PAAS.
I am passionate about learning and teaching. I strive to learn something new about PBM audits every day, so that PAAS can be more knowledgeable to better serve our members! In 2018, I started traveling to state pharmacy conferences to present audit seminars and meet our wonderful members in person.
I obtained my PharmD from the University of Wisconsin-Madison School of Pharmacy and worked for a major chain as well as various LTC and independent pharmacies, before coming to PAAS.
I am passionate about learning and teaching. I strive to learn something new about PBM audits every day, so that PAAS can be more knowledgeable to better serve our members! In 2018, I started traveling to state pharmacy conferences to present audit seminars and meet our wonderful members in person.
Latest posts by Eric Hartkopf, PharmD (see all)
- Dexcom G6/G7 Sensors: Retail vs DME - August 14, 2025
- COVID-19 Vaccine Update: Shared Clinical Decision-Making - August 8, 2025
- AstraZeneca Letters re: Farxiga® Data Discrepancies - August 2, 2025
